Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Human adipose-derived mesenchymal stem cell-derived exosomes induce epithelial remodeling and anti-scar healing revealed by single-cell RNA sequencing.

Fu Y., Xie JL., Zhang XL., Xie GM., Zhang XM., Han YT.

Animal Study on Chronic Wound, Scar, published in J Nanobiotechnology (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Nanobiotechnology (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
40660260
PMCID
PMC12261776
DOI
10.1186/s12951-025-03548-y
Citations
3

Abstract (original English)

The scar-free healing remains a clinical challenge, and requires the concerted efforts of multiple cell types, such as keratinocytes and fibroblasts. Exosomes derived from human adipose-derived mesenchymal stem cells (hADSC-Exos) have emerged as a promising therapeutic option. Nonetheless, a thorough understanding of the mechanisms underlying regenerative healing in response to hADSC-Exos treatment is still lacking. Here, we performed high-resolution single-cell RNA sequencing analysis of adult wild-type and hADSC-Exos-treated mice at postoperative day (POD) 14. hADSC-Exos influenced epithelial cells and fibroblasts, leading to scar-free wound healing. Among the epithelial cell subtypes, Lymphoid enhancer binding factor 1 high proliferating keratinocytes (prolif KC) are particularly remodeled by hADSC-Exos. Prolif KC exhibit epithelial-mesenchymal plasticity (EMP). Cell-cell communication between keratinocytes and fibroblasts during anti-scar healing is modulated by tumor growth factor-β1, which promotes the EMP transition cascade. hADSC-Exos may inhibit wound fibrosis through the 14-3-3 zeta-YES-associated protein-Hippo signaling pathway. This study enhances our understanding of epithelial cell diversity and interactions in wound healing, highlighting hADSC-Exo-induced prolif KC as a potential reprogramming target. These epithelial cells are promising therapeutic targets for i

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
ExosomesHumansMesenchymal Stem CellsAnimalsWound HealingMiceSingle-Cell AnalysisSequence Analysis, RNAKeratinocytesFibroblasts

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research